Larimar Therapeutics

+$0.29 (+2.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LRMR and other stocks, options, and ETFs commission-free!

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.

CEO
Carole S. Ben-Maimon
Employees
28
Headquarters
Bala Cynwyd, Pennsylvania
Founded
2005

LRMR Key Statistics

Market Cap
149.23M
Price-Earnings Ratio
Dividend Yield
Average Volume
288.12K
High Today
$14.01
Low Today
$12.38
Open Price
$13.10
Volume
69.76K
52 Week High
$25.87
52 Week Low
$8.00

LRMR Earnings

-$1.21
-$0.81
-$0.40
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.72 per share
Actual
-$0.76 per share

You May Also Like

ADAP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure